New York State Common Retirement Fund’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
Other funds holding LYEL
AVM
MM
FCMI
OPL
DC
AC
VP
FCMV
New York State Common Retirement Fund's LYEL Position: Q2 2025 in Review
New York State Common Retirement Fund sold out of Lyell Immunopharma (LYEL) in Q2 2025, closing a stake of 2,563 shares — an estimated $27.6K sold.
New York State Common Retirement Fund first reported a position in LYEL in Q3 2021 and held it in 15 quarters. The position peaked at $863K in Q3 2022. 69 funds tracked by Wall St. Rank hold LYEL as of Q2 2025.
- New York State Common Retirement Fund reported no remaining Lyell Immunopharma position as of Q2 2025 after selling out during the quarter.
- New York State Common Retirement Fund sold 2,563 Lyell Immunopharma shares in Q2 2025, an estimated $27.6K.
- New York State Common Retirement Fund first reported a position in Lyell Immunopharma in Q3 2021 and held it in 15 quarters.
- New York State Common Retirement Fund's Lyell Immunopharma position peaked at $863K in Q3 2022.
- 69 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2025.
Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.